Mulay James

DirectorCG Oncology, Inc. (CGON) · full profile →Form 4 · filed Sep 22, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$885K
Net Open-Market Flow
-$885K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 19, 2025Option exercise(M)4K$1.82$7K4K
Sep 19, 2025Sell(S)4K$38.99$139K0
Sep 18, 2025Option exercise(M)19K$1.82$35K19K
Sep 18, 2025Sell(S)19K$39.01$746K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 19, 2025Option exercise(M)4K$013K
Sep 18, 2025Option exercise(M)19K$016K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-210015) within minutes of acceptance. Every field above traces to the original document. Verify it directly: